Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ESPR Gross Margin

The Gross Margin of Esperion Therapeutics Inc (ESPR) is 79.36%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

ESPR Gross Margin - Historical Value
Date Value
2024-12-31 79.36%
2023-12-31 62.81%
2022-12-31 64.24%
2021-12-31 81.89%
2020-12-31 98.99%
ESPR Gross Margin - Peers Comparison